{"resourceType":"Bundle","id":"tests-031889e2-0353-4c2e-82c0-f422e15aacaa-bundle","type":"transaction","entry":[{"fullUrl":"https://madie.cms.gov/Patient/031889e2-0353-4c2e-82c0-f422e15aacaa","resource":{"resourceType":"Patient","id":"031889e2-0353-4c2e-82c0-f422e15aacaa","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient"]},"extension":[{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-race","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"1002-5","display":"American Indian or Alaska Native","userSelected":true}},{"url":"text","valueString":"American Indian or Alaska Native"}]},{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-ethnicity","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2135-2","display":"Hispanic or Latino","userSelected":true}},{"url":"text","valueString":"Hispanic or Latino"}]}],"identifier":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/v2-0203","code":"MR"}]},"system":"https://bonnie-fhir.healthit.gov/","value":"63232f15414ba67d4e1d1c29"}],"name":[{"family":"DENEXPass","given":["ProcedurePalliativeCare"]}],"gender":"male","birthDate":"2005-12-31"},"request":{"method":"PUT","url":"Patient/031889e2-0353-4c2e-82c0-f422e15aacaa"}},{"fullUrl":"https://madie.cms.gov/Encounter/encounter-inpatient-1c2a","resource":{"resourceType":"Encounter","id":"4a7f6e8f-cd1c-4408-a05e-72bf3364e009","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter"]},"status":"finished","class":{"system":"http://terminology.hl7.org/CodeSystem/v3-ActCode","code":"IMP","display":"inpatient"},"type":[{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"183452005","display":"Emergency hospital admission (procedure)","userSelected":true}]}],"subject":{"reference":"Patient/031889e2-0353-4c2e-82c0-f422e15aacaa"},"period":{"start":"2025-01-01T00:00:00.000+00:00","end":"2025-01-03T00:35:00.000+00:00"}},"request":{"method":"PUT","url":"Encounter/4a7f6e8f-cd1c-4408-a05e-72bf3364e009"}},{"fullUrl":"https://madie.cms.gov/MedicationRequest/schedule-iv-benzodiazepines-medications-1c2b","resource":{"resourceType":"MedicationRequest","id":"3c040381-0da4-4f0a-a5e2-f0458d88af98","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"discharge","display":"Discharge","userSelected":true}]}],"doNotPerform":false,"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1298088","display":"flurazepam hydrochloride 15 MG Oral Capsule","userSelected":true}]},"subject":{"reference":"Patient/031889e2-0353-4c2e-82c0-f422e15aacaa"},"authoredOn":"2025-01-03T00:05:00.000+00:00","requester":{"reference":"Practitioner/example","display":"Patrick Pump"}},"request":{"method":"PUT","url":"MedicationRequest/3c040381-0da4-4f0a-a5e2-f0458d88af98"}},{"fullUrl":"https://madie.cms.gov/MedicationRequest/medications-for-opioid-use-disorder-1c2b","resource":{"resourceType":"MedicationRequest","id":"b702ae1b-aa4e-433f-89b4-70140d6a0856","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest"]},"status":"active","intent":"order","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/medicationrequest-category","code":"discharge","display":"Discharge","userSelected":true}]}],"doNotPerform":false,"medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"1010600","display":"buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film","userSelected":true}]},"subject":{"reference":"Patient/031889e2-0353-4c2e-82c0-f422e15aacaa"},"authoredOn":"2025-01-01T00:05:00.000+00:00","requester":{"reference":"Practitioner/example","display":"Patrick Pump"}},"request":{"method":"PUT","url":"MedicationRequest/b702ae1b-aa4e-433f-89b4-70140d6a0856"}},{"fullUrl":"https://madie.cms.gov/Procedure/opioid-medication-assisted-treatment-1c2c","resource":{"resourceType":"Procedure","id":"e32a6852-778a-4c89-bcc6-72779420133f","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure"]},"extension":[{"url":"http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-recorded","valueDateTime":"2025-01-03T00:10:00.000+00:00"}],"status":"completed","code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"792902005","display":"Drug addiction therapy using buprenorphine and naloxone (regime/therapy)","userSelected":true}]},"subject":{"reference":"Patient/031889e2-0353-4c2e-82c0-f422e15aacaa"},"performedDateTime":"2025-01-01T00:10:00.000+00:00"},"request":{"method":"PUT","url":"Procedure/e32a6852-778a-4c89-bcc6-72779420133f"}},{"fullUrl":"https://madie.cms.gov/Coverage/1","resource":{"resourceType":"Coverage","id":"2577d1f8-1480-4dde-b88e-05f76b1d01e4","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage"]},"status":"active","beneficiary":{"reference":"Patient/031889e2-0353-4c2e-82c0-f422e15aacaa"},"payor":[{"reference":"Organization/80573fa1-cf83-4e9a-8f21-86a018689678"}]},"request":{"method":"PUT","url":"Coverage/2577d1f8-1480-4dde-b88e-05f76b1d01e4"}},{"fullUrl":"https://madie.cms.gov/Organization/123456","resource":{"resourceType":"Organization","id":"80573fa1-cf83-4e9a-8f21-86a018689678","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-organization"]},"identifier":[{"use":"temp","system":"urn:oid:2.16.840.1.113883.4.4","value":"21-3259825"}],"active":true,"type":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/organization-type","code":"pay","display":"Payer"}]}],"name":"Blue Cross Blue Shield of Texas","telecom":[{"system":"phone","value":"(+1) 972-766-6900"}],"address":[{"use":"billing","type":"postal","line":["P.O. Box 660044"],"city":"Dallas","state":"TX","postalCode":"75266-0044","country":"USA"}]},"request":{"method":"PUT","url":"Organization/80573fa1-cf83-4e9a-8f21-86a018689678"}},{"fullUrl":"https://madie.cms.gov/MeasureReport/a63418db-ca97-4bac-a588-af73f169d1cf","resource":{"resourceType":"MeasureReport","id":"a63418db-ca97-4bac-a588-af73f169d1cf","meta":{"profile":["http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/test-case-cqfm"]},"contained":[{"resourceType":"Parameters","id":"27eed5b5-7589-4479-a43e-87c63ee2ea9a-parameters","parameter":[{"name":"subject","valueString":"031889e2-0353-4c2e-82c0-f422e15aacaa"}]}],"extension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-inputParameters","valueReference":{"reference":"#27eed5b5-7589-4479-a43e-87c63ee2ea9a-parameters"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-testCaseDescription","valueMarkdown":"Enc first day of MP, pt in MAT program for opioids, tx plan includes buprenorhine tx. "}],"modifierExtension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-isTestCase","valueBoolean":true}],"status":"complete","type":"individual","measure":"https://madie.cms.gov/Measure/SafeUseofOpioidsConcurrentPrescribingFHIR","period":{"start":"2025-01-01","end":"2025-12-31"},"group":[{"population":[{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"initial-population","display":"Initial Population"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator","display":"Denominator"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator-exclusion","display":"Denominator Exclusion"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"numerator","display":"Numerator"}]},"count":0}]}]},"request":{"method":"PUT","url":"MeasureReport/a63418db-ca97-4bac-a588-af73f169d1cf"}}]}